RU98109592A - APPLICATION OF PROTEIN S-100B IN MEDICINES AND MEDICINES CONTAINING PROTEIN S-100B - Google Patents

APPLICATION OF PROTEIN S-100B IN MEDICINES AND MEDICINES CONTAINING PROTEIN S-100B

Info

Publication number
RU98109592A
RU98109592A RU98109592/14A RU98109592A RU98109592A RU 98109592 A RU98109592 A RU 98109592A RU 98109592/14 A RU98109592/14 A RU 98109592/14A RU 98109592 A RU98109592 A RU 98109592A RU 98109592 A RU98109592 A RU 98109592A
Authority
RU
Russia
Prior art keywords
protein
medicines
neurons
application
damaged
Prior art date
Application number
RU98109592/14A
Other languages
Russian (ru)
Inventor
Г.Хаглид Кеннет
Original Assignee
А+Сайенс Инвест АБ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by А+Сайенс Инвест АБ filed Critical А+Сайенс Инвест АБ
Publication of RU98109592A publication Critical patent/RU98109592A/en

Links

Claims (6)

1. Применение белка S-100b в лекарственных средствах, которые стимулируют рост и выживание поврежденных нейронов.1. The use of protein S-100b in drugs that stimulate the growth and survival of damaged neurons. 2. Применение по п. 1 для лечения нейронов, имеющих рецепторы к S-100b в и/или содержащих S-100b. 2. The use according to claim 1 for the treatment of neurons having receptors for S-100b in and / or containing S-100b. 3. Применение S-100b по любому из пп. 1-2 для нейронов, которые повреждены в результате заболеваний, таких как боковой амиотрофический склероз или рассеянный склероз. 3. The use of S-100b according to any one of paragraphs. 1-2 for neurons that are damaged by diseases such as amyotrophic lateral sclerosis or multiple sclerosis. 4. Лекарственное средство, содержащее протеин S-100b для стимулирования роста и выживания поврежденных нейронов. 4. A drug containing protein S-100b to stimulate the growth and survival of damaged neurons. 5. Лекарственное средство по п. 4, в котором S-100b используют в концентрации 0,1 - 100 мкг/мл в водном растворе, который может содержать также другие биологически совместимые вещества. 5. The drug according to claim 4, in which S-100b is used at a concentration of 0.1-100 μg / ml in an aqueous solution, which may also contain other biocompatible substances. 6. Способ введения лекарственного средства по любому из пп. 4 или 5 путем инфузии или инъекции с использованием, например, миниосмотического насоса. 6. The method of administration of the drug according to any one of paragraphs. 4 or 5 by infusion or injection using, for example, a mini-osmotic pump.
RU98109592/14A 1995-10-17 1996-10-15 APPLICATION OF PROTEIN S-100B IN MEDICINES AND MEDICINES CONTAINING PROTEIN S-100B RU98109592A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9503620-8 1995-10-17

Publications (1)

Publication Number Publication Date
RU98109592A true RU98109592A (en) 2000-05-20

Family

ID=

Similar Documents

Publication Publication Date Title
ES2526707T3 (en) Purification and stabilization of peptides and proteins in pharmaceutical agents
ATE185268T1 (en) ADVANCED DRUG DELIVERY SYSTEM AND METHOD FOR TREATING PSYCHIATRIC, NEUROLOGICAL AND OTHER DISEASES WITH CARBAMAZEPINE
PT693924E (en) PROCESSES FOR THE ADMINISTRATION (IN VIVO) OF BIOLOGICAL AND COMPOSITION SUBSTANCES USED IN THESE PROCESSES
ES2162615T3 (en) METHOD TO TREAT OR PREVENT TYPE 1 DIABETES THROUGH ORAL INSULIN ADMINISTRATION.
RU94022479A (en) Use of antiestrogenic compounds and pharmaceutically acceptable salts and solvents for blood glucose concentration decrease, pharmaceutical preparation
ATE298561T1 (en) ORAL DOSAGE FORM
EA200000468A1 (en) THERAPEUTIC COMPOSITION FOR THE ADMINISTRATION OF TOLTERODINE WITH CONTROLLED DELIVERY
RU94046251A (en) Glucagon-like peptide and derivatives of insulinotropine, method of synthesis, pharmaceutical compositions, method of diabetes treatment
DE68901140D1 (en) AQUEOUS SOLUTION OF FAT-SOLUBLE ACTIVE SUBSTANCES.
DE69232263T2 (en) RADICAL RECIPIENT ("SPIN TRAPS") FOR TREATING ILLNESSES ASSOCIATED WITH OXIDATION OF LIPIDES AND PROTEINS
DK0725648T3 (en) Liver-specific pharmaceutical active substances
WO2001022934A3 (en) Delivery of small doses of ingestible treatments
RU95101385A (en) Products containing g-csf and tnf-binding protein
RU98109592A (en) APPLICATION OF PROTEIN S-100B IN MEDICINES AND MEDICINES CONTAINING PROTEIN S-100B
SE9503620L (en) Use of the protein S-100b for the manufacture of drugs for nerve cells
RU2003113987A (en) METHOD FOR TREATMENT AND PREVENTION OF DISEASES BY EXPOSURE TO BIOLOGICALLY ACTIVE POINTS AND ZONES
RU95105249A (en) Ng monomethyl-l-arginine hydrochloride, processes for preparation thereof, process for preparation of pharmaceutical agent, and method of treatment
RU94013606A (en) Hemostimulator
KR880008813A (en) Drugs and methods of treating gastric hyperacidity in body secretion
RU92013625A (en) DRUGS, STIMULATING ERYTHROID GROWTH BLOOD DURING CYTOSTATIC MYELOPRESSIONS
RU2000101091A (en) METHOD FOR TREATING DYSTROPHIC DISEASES OF THE RETAIL AND VISUAL NERVE
RU93004536A (en) MEDICINE FOR PREVENTION AND THERAPY OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS THAT ARISE OUT OF ALCOHOL TREATMENT
KR920700041A (en) Therapeutic Compounds and Their Composition and Uses
RU95103961A (en) Method of chronic ischemic heart disease treatment
RU98109932A (en) APPLICATION OF 1- (2-NAFT-2-YLETHYL) -4- (3-TRIFLUOROMETHYLPHENYL) -1,2,3,6-TETHRHYDROPYRIDINE FOR THE PRODUCTION OF MEDICINES FOR THE TREATMENT OF LATERAL AMYOTRAFRAZIC